Filing summary
Entity identification: The supplied filing is BurTech Acquisition Corp.’s Form 10-Q, not a filing by Blaize Holdings, Inc. It covers the quarter ended June 30, 2022 and was signed August 15, 2022.
Business context and reporting period
BurTech was a blank-check company formed to pursue a business combination and had not commenced operating activities as of June 30, 2022. Its activity to date related to formation and its December 2021 IPO. It reported no operating revenue and stated it would not generate operating revenue before completing a business combination.
Financial results and position
| Metric | June 30, 2022 / period |
|---|---|
| Q2 net income | $93,322, including $394,047 of trust-account interest, offset by $220,049 of formation and operating costs and $80,676 of income tax expense |
| Six-month net loss | $3,600, versus a $500 loss from inception through June 30, 2021; the prior-year period is not directly comparable |
| Cash and trust investments | $621,578 in operating cash; $292.2 million in trust investments |
| Working capital | $715,923 |
| Cash flow, six months | $773,224 used in operating activities and $144,746 used in financing activities; cash declined $917,970 |
| Liabilities | $10.3 million total, including $10.1 million of deferred underwriting commissions payable upon a business combination; no promissory-note or working-capital-loan balance remained |
| Revenue and margins | No operating revenue; margins are not meaningful for this pre-combination SPAC |
Trust investments were classified as temporary equity for redemption purposes: 28.75 million public shares were recorded at $292.1 million, or $10.16 per share. Stockholders’ deficit was $9.1 million.
Changes versus comparable periods
Q2 2022 moved to net income from a $500 loss in Q2 2021, principally because of trust interest; Q2 2021 covered a newly formed company and had minimal activity. For the six months, the company reported a $3,600 loss versus a $500 loss for the 2021 inception-to-June period. Operating costs rose to $346,356 for the 2022 half-year, while trust interest income was $423,432. These periods differ substantially in length and stage of activity.
Outlook, risks, and unusual items
- The company had 15 months from its December 15, 2021 IPO to complete a business combination—through approximately March 15, 2023—unless shareholders approved an extension. Failure to complete a transaction could result in winding up, redemption of public shares, and warrants expiring worthless.
- Management said additional financing may be needed for working capital. Sponsor, officer, or director loans were possible but not committed; management warned financing may not be available and disclosed substantial doubt about the company’s ability to continue as a going concern.
- The $292.2 million trust balance was designated for a business combination or public-share redemptions, not ordinary operating expenses. The filing reported no assurance that public shareholders would receive $10.15 per share on redemption.
- The sponsor’s trust-account indemnity for certain third-party claims is limited; the company had not verified the sponsor’s ability to meet it and noted the sponsor’s assets were believed to consist only of company securities.
- Management cited potential effects from COVID-19, inflation, interest rates, supply-chain disruption, market volatility, and geopolitical instability, including the war in Ukraine. Specific impacts were not determinable.
- No business-combination guidance or target-specific outlook was provided. The filing reported no legal proceedings, no off-balance-sheet arrangements, and effective disclosure controls; no material quarterly change in internal control was reported.
Key facts investors should verify
- Confirm the intended issuer: this document identifies BurTech Acquisition Corp., not Blaize Holdings, Inc.
- Verify the company’s business-combination status and any subsequent extension, transaction, or liquidation developments after June 30, 2022.
- Assess the availability and terms of any working-capital financing, given the going-concern uncertainty and limited cash outside the trust.
- Review redemption and warrant terms, including the deferred underwriting commission and the risks of warrants expiring worthless.
- Confirm the trust balance, per-share redemption value, and any claims or withdrawals affecting funds available to public shareholders.